Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-076897

Options or other derivatives

  • Director acquired 1,583,214 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MOTT DAVID M Director 2024-07-01 Grant or award · Option to purchase Ordinary Shares +1,583,214 1,583,214 D
Loading xslF345X05/tm2418639-7_4seq1.xml…